Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) Qualitative (EUA)

  • Zoom
    Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) Qualitative (EUA)
  • Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) Qualitative (EUA)
Cat No: 31063
Assay Kits - More Assay Kits
Cayman

Quansys Biosciences’ SARS-CoV-2 Human IgG (4-Plex) Qualitative (EUA) Q-Plex multiplex assay is a qualitative enzyme-linked immunosorbent assay that detects IgG antibodies to SARS-CoV-2 in human serum or plasma. SARS-CoV-2 is the novel coronavirus that...

More
: 1 ea

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Correlated keywords:
  • 691649 HU anti-viral SARS-CoV-2 SARSCoV2 covid-19 covid19 coronavirus corona virus serological
Product Overview:
Quansys Biosciences’ SARS-CoV-2 Human IgG (4-Plex) Qualitative (EUA) Q-Plex multiplex assay is a qualitative enzyme-linked immunosorbent assay that detects IgG antibodies to SARS-CoV-2 in human serum or plasma. SARS-CoV-2 is the novel coronavirus that causes COVID-19. The SARS-CoV-2 virus has several structural proteins including two spike proteins, S1 and S2. When an individual is infected with the SARS-CoV-2 virus, their immune system produces antibodies to these viral proteins. The typical immune response produces detectable antibody levels ~8-10 days following the onset of symptoms. The SARS-CoV-2 Human IgG (4-Plex) Qualitative (EUA) Q-Plex Multiplex ELISA detects IgG antibodies to both the S1 and S2 spike proteins present in a blood sample. If antibodies are detected, the result will be considered positive. If antibodies are not detected, the result will be considered negative. The assay only detects IgG antibodies, not other classes of antibodies such as IgM or IgA. The multiplex assay allows for simultaneous indirect ELISA on the following for printed spots: SARS-CoV-2 Spike Glycoprotein (S1), a recombinant antigen which contains amino acids 1-674 of subunit 1. Spike S1 is expressed in mammalian HEK293 cells with a Sheep Fc-Tag. SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike subunit 2 protein, amino acids 685-1211. Spike S2 is expressed in mammalian HEK293 cells with a Sheep Fc-Tag. Sheep Fc, is a negative control to ensure no cross-reactivity occurs between human IgGs in the sample and the Fc-Tag on the SARS-Cov-2 Spike proteins. Anti-Human IgG is a positive control to ensure the kit performs and the IFU was followed correctly. Q-Plex™ plates are built by adsorbing multiple distinct capture antibodies in a defined array to the bottom of each well. Our high-quality reagents help ensure the accuracy of your results. See Item No. 28265 to view pricing and specifications for the Q-View™ Imager Pro or Item No. 28264 for the Q-View™ Imager LS. Species: Human Assay Type: Indirect Sample Type: Human Serum and Plasma Assay Length: 2 hours Specificity: See Assay Validation Volume Required per Well: 2 µl, minimum Detection Method: Chemiluminescent Multiplex Format: 96-well solid plate [Quansys Catalog No. 691649HU]
Size 1 ea
Shipping wet ice
Custom Code 3822.19
UNSPSC code 41116104

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

Search